clinical_trials
Tulisokibart Shows Promise in Hidradenitis Suppurativa
Confidence86·multiple reportsImportance88NP-EVT-20261022-69581A1
(MedPage Today) -- Results from a phase IIb study presented at the European Academy of Dermatology and Venereology meeting in Vienna showed promising efficacy with tulisokibart, an investigational tumor necrosis factor-like cytokine 1A (TL1A...
Read the original at the primary source
Tulisokibart Shows Promise in Hidradenitis Suppurativa
10/22/2026, 12:38:33 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —